Kinetics of equine neutrophil elastase release and superoxide anion generation following secretagogue activation: A potential mechanism for antiproteinase inactivation

Veterinary Immunology and Immunopathology

Volumn 72, Issue 3-4, 1999, Pages 257-275

  Dagleish, Mark P ^a   Pemberton, Alan D ^a   Brazil, Timothy J ^a   McAleese, Sybil M ^a   Miller, Hugh R P ^a   Scudamore, Cheryl L ^b  

^a WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Alpha 1 proteinase inhibitor; Elastase; Equine; Horse; Neutrophil

Indexed keywords

ALPHA 1 ANTITRYPSIN; EGTAZIC ACID; LEUKOCYTE ELASTASE; SUPEROXIDE; ZYMOSAN;

ANIMAL CELL; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HORSE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; KINETICS; NEUTROPHIL; NONHUMAN; REVIEW; SPECIES DIFFERENCE; TECHNIQUE;

EID: 0032778799     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(99)00144-0     Document Type: Article

References (69)

1. Allen R.C. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis. Methods Enzymol. 133:1986;449-493.
2. Beatty K., Bieth J., Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J. Biol. Chem. 255:1980;3931-3934.
3. Benbarek H., Debydupont G., Deby C., Caudron I., Mathyhartert M., Lamy M., Serteyn D. Experimental-model for the study by chemiluminescence of the activation of isolated equine leukocytes. Res. Vet. Sci. 61:1996;59-64.
4. Bieth, J.G., 1986. Elastases: catalytic and biological properties. In: Mecham, R. (Ed.), Regulation of Matrix Accumulation, Academic Press, New York.
5. Bokoch G.M. Chemoattractant signalling and leukocyte activation. Blood. 86:1995;1649-1660.
6. Buhl A.M., Avdi N., Worthen G.S., Johnson G.L. Mapping of the c5a receptor signal-transduction network in human neutrophils. Proc. Natl. Acad. Sci. USA. 91:1994;9190-9194.
7. Buhl R., Meyer A., Vogelmeier C. Oxidant-protease interaction in the lung - prospects for antioxidant therapy. Chest. 110:1996;S267-S272.
8. Campbell E.J., Silverman E.K., Campbell M.A. Elastase and cathepsin-g of human-monocytes - quantification of cellular content release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J. Immunol. 143:1989;2961-2968.
9. 1-antitrypsin and to the enzyme-inhibiting activity of plasma. Am. Rev. Respiratory Disease. 119:1979;953-960.
10. Cramer E.M., Beesley J.E., Pulford K.A.F., Bretongorius J., Mason D.Y. Colocalization of elastase and myeloperoxidase in human-blood and bone-marrow neutrophils using a monoclonal-antibody and immunogold. Am. J. Pathol. 134:1989;1275-1284.
11. Creagh, T., Krausz, T., 1992. Chronic obstructive airway disease. In: McGee, J.O., Isaacson, P.G., Wright, N.A. (Eds.), Oxford Textbook of Pathology, Oxford University Press, Oxford, pp. 974-980.
12. Dagleish M.P., Pemberton A.D., McAleese S.M., Thornton E.M., Miller H.R.P., Scudamore C.L. Improved hepatic and pancreatic localisation of the equine alpha-1- proteinase inhibitor family of serpins using an antigen enhancement technique and a monoclonal antibody. Res. Vet. Sci. 65:1998;215-221.
13. Dale D.C., Clark R.A., Root R.K., Kimball H.R. The Chediak-Higashi syndrome: studies of host defence. Ann. Int. Med. 76:1972;293-306.
14. Dixon P.M., Railton D.I., McGorum B.C. Equine pulmonary-disease - a case-control study of 300 referred cases 3. Ancillary diagnostic-findings. Equine Vet. J. 27:1995;428-435.
15. Downey G.P., Fukushima T., Fialkow L., Waddell T.K. Intracellular signalling in neutrophil priming and activation. Seminars Cell Biol. 6:1995;345-356.
16. Dubin A., Koj A., Chudiz J. Isolation and some molecular parameters of elastase-like neutral proteinases from horse blood leucocytes. Biochem. J. 153:1976;389-396.
17. Dubin A. A polyvalent proteinase inhibitor from horse-blood-leucocyte cytosol. Eur. J. Biochem. 73:1977;429-435.
18. Dubin A., Koj A. Proteinase inhibitors from horse plasma and leucocytes: properties and biological functions. Biomed. Biochim. Acta. 45:1986;1391-1396.
19. Dubin A., Travis J., Enghild J.J., Potempa J. Equine leukocyte elastase inhibitor - primary structure and identification as a thymosin-binding protein. J. Biol. Chem. 267:1992;6576-6583.
20. duBois R.M., Bernaudin J.F., Paakko P., Hubbard R., Takahashi H., Ferrans V., Crystal R.G. Human neutrophils express the alpha-1-antitrypsin gene and produce alpha-1-antitrypsin. Blood. 77:1991;2724-2730.
21. Edelman N.H., Kaplan R.M., Buist A.S., Cohen A.B., Hoffman L.A., Kleinhenz M.E., Snider G.L., Speizer F.E. Chronic obstructive pulmonary-disease. Chest. 102:1992;243-256.
22. Fouret P., duBois R.M., Bernaudin J.F., Takahashi H., Ferrans V.J., Crystal R.G. Expression of the neutrophil elastase gene during human-bone marrow cell differentiation. J. Exp. Med. 169:1989;833-845.
23. Freeman K.P., Roszel J.F., Mcclure J.M., Mannsman R., Patton P.E., Naile S. A review of cytological specimens from horses with and without clinical signs of respiratory-disease. Equine Vet. J. 25:1993;523-526.
24. Gadek J.E., Klein H.G., Holland P.V., Crystal R.G. Replacement therapy of alpha-1-antitrypsin deficiency - reversal of protease-antiprotease imbalance within the alveolar structures of piz subjects. J. Clin. Inves. 68:1981;1158-1165.
25. Gadek J.E., Fells G.A., Zimmerman R.L., Rennard S.I., Crystal R.G. Anti-elastases of the human alveolar structures - implications for the protease-antiprotease theory of emphysema. J. Clin. Inves. 68:1981;889-898.
26. Ganz T., Metcalf J.A., Gallin J.I., Boxer L.A., Lehrer R.I. Microbicidal cyto-toxic proteins of neutrophils are deficient in 2 disorders - chediak-higashi-syndrome and specific granule deficiency. J. Clin. Inves. 82:1988;552-556.
27. Ganz T., Metcalf J.A., Gallin J.I., Lehrer R.I. 2-genetic-disorders that affect human neutrophils (pmn) are associated with deficiencies of microbicidal and cyto-toxic granule proteins. Clin. Res. 35:1987;424.
28. Haslett C., Guthrie L.A., Kopaniak M.M., Johnston R.B., Henson P.M. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am. J. Pathol. 119:1985;101-110.
29. Haslett C., Savill J.S., Meagher L. The neutrophil. Curr. Opin. Immunol. 2:1989;10-18.
30. Hayes J.A., Korthy A., Snider G.L. The pathology of elastase-induced panacinar emphysema in hamsters. J. Pathol. 117:1975;1-14.
31. Henson P.M., Johnston R.B. Tissue-injury in inflammation - oxidants, proteinases, and cationic proteins. J. Clin. Inves. 79:1987;669-674.
32. Horie N., Fukuyama K., Ito Y., Epstein W.L. Detection and characterization of epidermal proteinases by polyacrylamide-gel electrophoresis. Comp. Biochem. Physiol. B. 77:1984;349-353.
33. Hubbard R.C., Ogushi F., Fells G.A., Cantin A.M., Jallat S., Courtney M., Crystal R.G. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J. Clin. Inves. 80:1987;1289-1295.
34. Hubbard R.C., Brantly M.L., Sellers S.E., Mitchell M.E., Crystal R.G. Anti-neutrophil-elastase defences of the lower respiratory-tract in alpha-1-antitrypsin deficiency directly augmented with an aerosol of alpha-1-antitrypsin. Ann. Int. Med. 111:1989;206-212.
35. Janoff A., Sloan B., Weinbaum G., Damiano V., Sandhaus R.A., Elias J., Kimbel P. Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am. Rev. Respiratory Disease. 115:1977;461-478.
36. Johnson D., Travis J. The oxidative inactivation of human α-1-proteinase inhibitor. J. Biol. Chem. 254:1979;4022-4026.
37. Kaup F.J., Drommer W., Damsch S., Deegen E. Ultrastructural findings in horses with chronic obstructive pulmonary-disease (copd) 2. Pathomorphological changes of the terminal airways and the alveolar region. Equine Vet. J. 22:1990;349-355.
38. Khalfi F., Gressier B., Brunet C., Dine T., Luyckx M., Cazin M., Cazin J.C. Involvement of the extracellular calcium in the release of elastase and the human neutrophils oxidative burst. Cell. Mol. Biol. 42:1996;1211-1218.
39. Korchak H.M., Vienne K., Rutherford L.E., Weissmann G. Neutrophil stimulation - receptor, membrane, and metabolic events. Federation Proceedings. 43:1984;2749-2754.
40. Kordula T., Dubin A., Schooltink H., Koj A., Heinrich P.C., RoseJohn S. Molecular cloning and expression of an intracellular serpin: an elastase inhibitor from horse leucocytes. Biochem. J. 293:1993;187-193.
41. Korzus E., Dubin A., Potempa J., Travis J. Elastase inhibitor from mammalian neutrophil cytosol. Biomed. Biochim. Acta. 50:1991;687-690.
42. 1-antitrypsin deficiency. Scandinavian J. Clin. Lab. Inves. 15:1963;132-140.
43. Mason D.Y., Cramer E.M., Masse J.M., Crystal R., Bassot J.M., Bretongorius J. Alpha 1-antitrypsin is present within the primary granules of human polymorphonuclear leukocytes. Am. J. Pathol. 139:1991;623-628.
44. Mast A.E., Enghild J.J., Nagase H., Suzuki K., Pizzo S.V., Salvesen G. Kinetics and physiological relevance of the inactivation of alpha 1-proteinase inhibitor, alpha-1-antichymotrypsin, and antithrombin-iii by matrix metalloproteinases-1 (tissue collagenase), metalloproteinases-2 (72 kda gelatinase type-iv collagenase), and metalloproteinases-3 (stromelysin). J. Biol. Chem. 266:1991;15810-15816.
45. Matheson N.R., Janoff A., Travis J. Enzymatic oxidation of alpha-1-proteinase inhibitor in abnormal tissue turnover. Mol. Cell. Biochem. 45:1982;65-71.
46. Nakajima K., Powers J.C., Ashe B.M., Zimmerman M. Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. J. Biol. Chem. 254:1979;4027-4032.
47. Ohlsson K. Interactions between granulocyte proteases and protease inhibitors in the lung. Bull. Europ. Physiopath. Resp. 16:1980;209-222.
48. Ossanna P.J., Test S.T., Matheson N.R., Regiani S., Weiss S.J. Oxidative regulation of neutrophil elastase alpha-1-proteinase inhibitor interactions. J. Clin. Inves. 77:1986;1939-1951.
49. Ottonello L., Dapino P., Pastorino G., Vitale E., Dallegri F. The drug 5-aminosalicylic acid rescues alpha(1)-proteinase inhibitor from the neutrophil oxidative inactivation - a possible contribution to its therapeutic action in ulcerative-colitis. Digestion. 51:1992;140-145.
50. Padrines M., Schneiderpozzer M., Bieth J.G. Inhibition of neutrophil elastase by alpha-1-proteinase inhibitor oxidized by activated neutrophils. Am. Rev. Respiratory Disease. 139:1989;783-790.
51. Patterson S.D., Bell K. Application of an affinity electrophoretic and in situ oxidation method to the study of the equine protease inhibitory proteins. Electrophoresis. 10:1989;40-45.
52. Patterson S.D., Bell K., Shaw D.C. The equine major plasma serpin multigene family - partial characterization including sequence of the reactive-site regions. Biochem. Genetics. 29:1991;477-499.
53. Perlmutter D.H. Alpha-1-antitrypsin deficiency - biochemistry and clinical manifestations. Ann. Med. 28:1996;385-394.
54. Potempa J., Dubin A., Watorek W., Travis J. An elastase inhibitor from equine leukocyte cytosol belongs to the serpin superfamily - further characterization and amino-acid sequence of the reactive centre. J. Biol. Chem. 263:1988;7364-7369.
55. Potempa J., Wunderlich J.K., Travis J. Comparative properties of 3 functionally different but structurally related serpin variants from horse plasma. Biochem. J. 274:1991;465-471.
56. Ras G.J., Theron A.J., Anderson R., Taylor G.W., Wilson R., Cole P.J., Vandermerwe C.A. Enhanced release of elastase and oxidative inactivation of alpha-1- protease inhibitor by stimulated human neutrophils exposed to pseudomonas-aeruginosa pigment 1-hydroxyphenazine. J. Infect. Diseases. 166:1992;568-573.
57. Robinson N.E., Derksen F.J., Olszewski M.A., Buechnermaxwell V.A. The pathogenesis of chronic obstructive pulmonary-disease of horses. Br. Vet. J. 152:1996;283-306.
58. Roos D. The respiratory burst of phagocytic leucocytes. Drug Investigation. 3:1991;48-53.
59. Rossi F. The o-2(-)-forming nadph oxidase of the phagocytes - nature, mechanisms of activation and function. Biochimica et Biophysica Acta. 853:1986;65-89.
60. Sallenave J.M., Har M.S.T., Cox G., Chignard M., Gauldie J. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J. Leukocyte Biol. 61:1997;695-702.
61. Scudamore C.L., Pemberton A., Watson E.D., Miller H.R.P. Neutrophil chemotaxis in the horse is not mediated by a complex of equine neutrophil elastase and equine alpha-1-proteinase inhibitor. Br. Vet. J. 149:1993;331-338.
62. Scudamore C.L., Pemberton A.D., Miller H.R.P., Mcdonnell A.M., Thomson S.R.M., Dawson A., Watson E.D. Measurement by elisa of equine alpha-1-proteinase inhibitor in uterine flushings from mares. Res. Vet. Sci. 57:1994;45-52.
63. Seetoo K.F., Schonhorn J.E., Gewirtz A.T., Zhou M.J., McMenamin M.E., Delva L., Simons E.R. A cytosolic calcium transient is not necessary for degranulation or oxidative burst in immune complex-stimulated neutrophils. J. Leukocyte Biol. 62:1997;329-340.
64. Shapiro S.D. The pathogenesis of emphysema - the elastase-antielastase hypothesis 30 years later. Proc. Assoc. Am. Physicians. 107:1995;346-352.
65. Snider G.L. Emphysema: the first two centuries-and beyond. A historical overview with suggestions for future research: part 2. Am. Rev. Respir. Diseases. 146:1992;1615-1622.
66. Tetley T.D., Smith S.F., Winning A.J., Foxall J.M., Cooke N.T., Burton G.H., Harris E., Guz A. The acute effect of cigarette-smoking on the neutrophil elastase inhibitory capacity of peripheral lung lavage from asymptomatic volunteers. Eur. Respiratory J. 2:1989;802-810.
67. Travis J., Beatty K., Wong P.S., Matheson N.R. Oxidation of alpha-1-proteinase inhibitor as a major contributing factor in the development of pulmonary-emphysema. Clin. Respiratory Physiol.-Bull. Eur. De Physiopatholgie Respiratoire. 16:1980;341-352.
68. Travis J., Salvesen G.S. Human-plasma proteinase-inhibitors. Ann. Rev. Biochem. 52:1983;655-709.
69. Von Fellenberg R., Kohler L., Grunig G., Pellegrini A. Comparison of neutrophil elastase and of neutrophil protease inhibitors in the horse and man. Am. J. Vet. Res. 46:1985;2480-2484.